AzTrials
AzTrials

Male InfertilityNCT06257459

Excision Versus Preservation of Spermatic Cord Lipoma Detected During Subinguinal Varicocelectomy

A study testing subinguinal varicocelectomy in people with Male Infertility, run by Tanta University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the current study, the adult infertile patients with clinical varicoceles will be included. the patients will undergo subinguinal varicocelectomy. The patients with spermatic cord lipoma detected at the time of surgery will be enrolled and divided into 2 groups( excision group, group A and preservation group (B). Read more about this study

Who is it for?
Ages 18 to 50 years, men onlyHealthy volunteers can take part
Conditions the study is for
Male Infertility
What is being tested?
subinguinal varicocelectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteEgypt
Study dates
1 Jan 2023to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adult infertile males
  • Clinical varicocele
  • Semen analysis show oligo-athenospermia

Who cannot join

  • Adolescent varicocele
  • Recurrent varicocele
  • Presence of inguinal hernia
  • Azospermic patients

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Ahmed Zoeir

    Tanta, Gharbia Governorate, 11511

    Ahmed Zoeir, +201008634198, drahmedzoeir27@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Excision Versus Preservation of Spermatic Cord Lipoma Detected During Subinguinal Varicocelectomy in Infertile Men With Oligo-asthenzoospermia: A Prospective Randomized Trial.

In the current study, the adult infertile patients with clinical varicoceles will be included. the patients will undergo subinguinal varicocelectomy. The patients with spermatic cord lipoma detected at the time of surgery will be enrolled and divided into 2 groups( excision group, group A and preservation group (B). semen parameters will be compared in both group at 3 and 6 months after surgery

Read the detailed description

This will be a prospective randomized study, in which adult infertile patients with clinical varicocele and oligo-athenospermia admitted to Urology department Tanta university hospital will be included and then the patients with detected spermatic cord lipoma at the time surgery will be enrolled and divided into 2 groups:

GROUP A : will undergo subinguinal varicocelectomy with excision of spermatic cord lipoma GROUP B : will undergo subinguinal varicocelectomy with preservation of spermatic cord lipoma

Inclusion criteria:

  • Adult infertile males
  • Clinical varicocele
  • oligo-asthenospermia

Exclusion criteria:

  • Adolescent varicocele
  • Recurrent varicocele
  • Presence of inguinal hernia
  • Azospermic patients
Being tested
subinguinal varicocelectomy
Medical subject headings
Infertility, Male

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • subinguinal varicocelectomyProcedure or surgery

    exision or preservation of spermatic cord lipoma during subinguinal varicocelectomy

Study groups in NCT06257459
Study groupRoleWhat they receive
Lipoma Excision (group A)Active comparatorexcison of spermatic cord lipoma detected during subinguinal varicocelectomy in infertile males
Receives: Procedure: subinguinal varicocelectomy
Lipoma Preservation (group B)Active comparatorpreservation of spermatic cord lipoma detected during subinguinal varicocelectomy in infertile males
Receives: Procedure: subinguinal varicocelectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. semen parameters improvement

    semen analysis

    Measured: 3 and 6 months after surgery

  2. symptoms improvement (pain and swelling)

    improvement of preoperative scrotal pain and swelling was assessed

    Measured: 3 and 6 months after surgery

Secondary outcomes (1)
  1. postoperative complications

    post-operative scrotal edema, hematoma and wound infection were assessed

    Measured: early after surgery and late

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2024
  2. Study start1 Jan 2023
  3. Primary completion1 Jun 2024 (estimated)
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06257459
Sponsor's protocol ID
36137/12/22
Status last verified
Feb 2024
First submitted
30 Jan 2024
Last updated
14 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing subinguinal varicocelectomy in people with Male Infertility, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

semen parameters improvement (time frame: 3 and 6 months after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in